Searched for
DIABETES DRUG FARXIGA
Lilly's weight-loss pill shows better blood sugar control in late-stage trialsEli Lilly's experimental oral weight-loss drug, orforglipron, demonstrated superior blood sugar control in diabetic patients across two lat...- AstraZeneca drug lowers high blood pressure in late-stage studyAstraZeneca's baxdrostat demonstrated significant blood pressure reduction in a late-stage trial for treatment-resistant hypertension, boos...
- AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
- AstraZeneca says on track to deliver on Covid shots as sales hit $275 mnWhen including production and distribution from partners such as the Serum Institute of India, more than 300 million doses have been suppli...
- AstraZeneca says diabetes drug Farxiga fails in COVID-19 studyThe British drugmaker said the drug did not achieve statistical significance in cutting the risk of the disease worsening and death in such...
- Natco launches cut-price copies of AstraZeneca's patented anti-diabetes drugThe launch gives Natco an entry in the rapidly growing SGLT-2 segment that has mostly been dominated by global drug makers. However, for ro...
- Alembic Pharma gets tentative nod from USFDA for glycemic control drugQuoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months, ending D...
Load More